Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Supported by an independent educational grant from Bristol Myers Squibb

1.0

Claim your AMA PRA Category 1 Credit, CNE Contact Hour or CPE Contact Hour (CEU)

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

No data was found

Des experts internationaux évaluent de nouvelles données sur l’inhibition de l’aldostérone...

Integrating Next-Generation Acid Suppression into Practical Algorithms for Gastroenterolog...

PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians